Press Release

Alpha Innotech and Panomics Announce Strategic Alliance for Genetic Arrays

Redwood City, Calif. October 5, 2001—Alpha Innotech Corporation and Panomics, Inc. have announced a strategic alliance to co-market their respective FluorChem™ fluorescence and chemiluminescence imaging system and the chemiluminescence based membrane array products. Panomics' new Protein/DNA Array simplifies the functional analysis of eukaryotic transcription factors (TF). This array-based technology is a significant improvement over cumbersome gel mobility-shift assays, which permit the characterization of one TF at a time. With Panomic's arrays, you can profile the activities of 54 TFs simultaneously. Arrays can be used to study TF activation in a variety of biological processes, including cell proliferation, differentiation, transformation, apoptosis, and drug treatment.

The FluorChem imaging system from Alpha Innotech Corporation provides a digital alternative to film for acquiring and analyzing chemiluminescent labeled blots or arrays. The FluorChem generates high resolution, wide dynamic range, and instant digital access to image acquisition with automatic exposure determination with the simple click of a button and provides comprehensive quantitative analysis features for array experiments.

About Alpha Innotech Corporation

Alpha Innotech Corporation is an innovative supplier of integrated discovery solutions for genomic research and drug discovery with core expertise in quantitative imaging, informatics, and molecular biology. Alpha Innotech maintains its corporate offices in San Leandro, CA, has over 15,000 global customers, with direct offices and distribution in over 35 countries.

About Panomics, Inc.

At Panomics, our mission is to develop innovative research tools for the exploration of postgenomic frontiers. Our core expertise is in signal transduction, biochemistry, and molecular biology.